- Home
- AFBI vs LUNG Comparison
AFBI vs LUNG Comparison
Compare AFBI & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFBI
- LUNG
- Stock Information
- Founded
- AFBI 1928
- LUNG 1995
- Country
- AFBI United States
- LUNG United States
- Employees
- AFBI N/A
- LUNG N/A
- Industry
- AFBI Major Banks
- LUNG Industrial Specialties
- Sector
- AFBI Finance
- LUNG Health Care
- Exchange
- AFBI Nasdaq
- LUNG Nasdaq
- Market Cap
- AFBI 117.0M
- LUNG 124.0M
- IPO Year
- AFBI N/A
- LUNG 2020
- Fundamental
- Price
- AFBI $18.47
- LUNG $2.72
- Analyst Decision
- AFBI
- LUNG Buy
- Analyst Count
- AFBI 0
- LUNG 6
- Target Price
- AFBI N/A
- LUNG $11.53
- AVG Volume (30 Days)
- AFBI 3.8K
- LUNG 310.5K
- Earning Date
- AFBI 07-25-2025
- LUNG 07-30-2025
- Dividend Yield
- AFBI 8.13%
- LUNG N/A
- EPS Growth
- AFBI N/A
- LUNG N/A
- EPS
- AFBI 0.91
- LUNG N/A
- Revenue
- AFBI $31,043,000.00
- LUNG $87,473,000.00
- Revenue This Year
- AFBI N/A
- LUNG $18.02
- Revenue Next Year
- AFBI N/A
- LUNG $18.17
- P/E Ratio
- AFBI $20.23
- LUNG N/A
- Revenue Growth
- AFBI 4.89
- LUNG 19.84
- 52 Week Low
- AFBI $17.00
- LUNG $2.50
- 52 Week High
- AFBI $22.50
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- AFBI 54.01
- LUNG 39.14
- Support Level
- AFBI $18.37
- LUNG $2.52
- Resistance Level
- AFBI $18.69
- LUNG $2.84
- Average True Range (ATR)
- AFBI 0.18
- LUNG 0.16
- MACD
- AFBI 0.01
- LUNG 0.03
- Stochastic Oscillator
- AFBI 46.72
- LUNG 28.50
About AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.